Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.9 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.028 | 0.9 |
mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0097 | 0.9 |